妥布霉素
粘菌素
医学
痰
铜绿假单胞菌
支气管扩张
B组
环丙沙星
抗生素
雾化器
安慰剂
痰培养
A组
肺活量测定
内科学
胃肠病学
麻醉
外科
微生物学
庆大霉素
哮喘
细菌
肺
病理
肺结核
替代医学
生物
遗传学
作者
Maria Kaponi,Τheodoros Karampitsakos,Αrgyris Τzouvelekis,Serafeim Chrysikos,Myrsini Melachroinidou,Anna Gousiou,Demosthenes E. Bouros,Christina Triantafillidou,Katerina Dimakou
出处
期刊:The European respiratory journal
[European Respiratory Society]
日期:2017-09-01
卷期号:: OA1971-OA1971
被引量:4
标识
DOI:10.1183/1393003.congress-2017.oa1971
摘要
Introduction: There is limited information on the eradication treatment in non CF Bronchiectasis (NCFB) patients with Pseudomonas aeruginosa (Pa) in sputum. Aim: To evaluate the effect of inhaled tobramycin and colistin on eradication of Pa in patients with NCFB. Methods: Fifty two patients were studied (33 women), mean age58.6+15.2 years, with >104 CFU of Pa/ ml in sputum culture. All patients received ciprofloxacin 750 mg bid for 14 days. They were then randomized in 3 groups and received: Tobramycin (Tobi, Novartis) 300mgx2 (group A, n=17), Colistimethate sodium (Colistin, Norma) 1MUx2 (group B, n=18), placebo N/S 0.9% 4ccx2 (group C, n=17). Administration was done through Pari LC Plus jet nebulizer for 3 months. Sputum culture, volume and purulence, dyspnea, spirometry and SaO2 were estimated before and after treatment. Results: In groups A and B a significant reduction in Pa density as well as in sputum volume was found compared to placebo (mean Δlog10 CFUs=2.1 vs 1.1 and 2.7 vs 1.1, p<0.001 and mean Δvolume (ml)= 11.2 vs 2.2 and 11.4 vs 2.2, p<0.0001 respectively).Eradication was observed in 47%, 39% and 17.6% of patients in groups A, B and C respectively. Improvement in sputum purulence was also found in group A and B compared to placebo (Mean Δ+ SD= -1.3+0.8vs-0.5+0.6, p=0.0026 and -1.1+1vs -0.5+0.6, p= 0.03 respectively).Differences in MRC scale , spirometry and SaO2 were not significant. Conclusion: Our findings indicate that inhaled antibiotics, tobramycin and colistin, may be effective in eradicating Pa, reducing bacterial load and improving symptoms of bronchiectatic patients. Further investigation is required.
科研通智能强力驱动
Strongly Powered by AbleSci AI